Europe Legal Chronicle. August 26, 2022

ADC Therapeutics’ $175 Million Senior Secured Term Loan and Existing Senior Secured Convertible Notes from Owl Rock and Oaktree

By Federica Tiefenthaler

Homburger and Davis Polk & Wardwell advised ADC Therapeutics on the deal. DC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced that it...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here